Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Dupuis

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Presse Medicale (Paris, France : 1983)|February 23, 2013
[Anti-VEGF: a new therapeutic option in hereditary hemorrhagic telangiectasia]Sophie Dupuis-Girod
Mayo Clinic Proceedings|August 6, 2020
Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia: A Role That Is Still to Be DefinedSophie Dupuis-Girod
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2016
Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?Sophie Dupuis-Girod, Elisabetta Buscarini
La Revue Du Praticien|October 21, 2009
[Hereditary hemorrhagic telangiectasia]Henri Plauchu, Sophie Dupuis-Girod
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2017
Response to Bevacizumab for the treatment of Rendu-Osler disease-A note of cautionSophie Dupuis-Girod, Elisabetta Buscarini
Medecine Sciences : M/S|October 9, 2010
[Rendu-Osler disease: clinical and molecular update]Sabine Bailly, Sophie Dupuis-Girod, Henri Plauchu
Orphanet Journal of Rare Diseases|January 9, 2020
Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literatureOlivier Dupuis, Laura Delagrange, Sophie Dupuis-Girod
Respiration; International Review of Thoracic Diseases|August 30, 2017
The Lung in Hereditary Hemorrhagic TelangiectasiaSophie Dupuis-Girod, Vincent Cottin, C L Shovlin
Molecular and Cellular Biology|January 26, 2002
Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunitTara J Moriarty, Sylvain Huard, Sophie Dupuis, et al.
CVIR Endovascular|March 16, 2024
Conservative management by embolization of a ruptured renal arterio-venous malformation (AVM) in Hereditary Hemorrhagic Telangiectasia (HHT)Romain L'Huillier, Gaële Pagnoux, Sophie Dupuis-Girod, et al.
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Presse Medicale (Paris, France : 1983)|February 23, 2013
[Anti-VEGF: a new therapeutic option in hereditary hemorrhagic telangiectasia]Sophie Dupuis-Girod
Mayo Clinic Proceedings|August 6, 2020
Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia: A Role That Is Still to Be DefinedSophie Dupuis-Girod
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2016
Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?Sophie Dupuis-Girod, Elisabetta Buscarini
La Revue Du Praticien|October 21, 2009
[Hereditary hemorrhagic telangiectasia]Henri Plauchu, Sophie Dupuis-Girod
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2017
Response to Bevacizumab for the treatment of Rendu-Osler disease-A note of cautionSophie Dupuis-Girod, Elisabetta Buscarini
Medecine Sciences : M/S|October 9, 2010
[Rendu-Osler disease: clinical and molecular update]Sabine Bailly, Sophie Dupuis-Girod, Henri Plauchu
Orphanet Journal of Rare Diseases|January 9, 2020
Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literatureOlivier Dupuis, Laura Delagrange, Sophie Dupuis-Girod
Respiration; International Review of Thoracic Diseases|August 30, 2017
The Lung in Hereditary Hemorrhagic TelangiectasiaSophie Dupuis-Girod, Vincent Cottin, C L Shovlin
Molecular and Cellular Biology|January 26, 2002
Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunitTara J Moriarty, Sylvain Huard, Sophie Dupuis, et al.
CVIR Endovascular|March 16, 2024
Conservative management by embolization of a ruptured renal arterio-venous malformation (AVM) in Hereditary Hemorrhagic Telangiectasia (HHT)Romain L'Huillier, Gaële Pagnoux, Sophie Dupuis-Girod, et al.
Pageof 17